- $1.18bn
- $940.42m
- $299.27m
- 87
- 14
- 82
- 64
Annual income statement for Amplitude, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 102 | 167 | 238 | 276 | 299 |
| Cost of Revenue | |||||
| Gross Profit | 72 | 115 | 168 | 204 | 222 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 126 | 241 | 335 | 379 | 407 |
| Operating Profit | -24 | -74.1 | -96.6 | -103 | -107 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -23.7 | -74 | -92.6 | -89.1 | -92.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -24.6 | -75 | -93.4 | -90.4 | -94.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -24.6 | -75 | -93.4 | -90.4 | -94.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24.6 | -75 | -93.4 | -90.4 | -94.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.24 | -0.682 | -0.838 | -0.727 | -0.761 |
| Dividends per Share |